| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 47,929 | 45,751 | 49,013 | 53,323 | | Cost of Revenue | 11,883 | 13,546 | 13,993 | 14,450 | | | Gross Profit | 36,046 | 32,205 | 35,020 | 38,873 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 23,069 | 22,359 | 19,461 | 21,523 | | Non Recurring |
-
|
-
| 2,369 | (848) | | Others | 22,327 | 12,582 | 9,352 | 7,469 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,350) | (2,736) | 3,838 | 10,729 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (9,350) | (2,736) | 3,838 | 10,729 | | Interest Expense | 6,732 | 7,059 | 7,308 | 7,434 | | Income Before Tax | (16,082) | (9,795) | (3,470) | 3,295 | | Income Tax Expense | 7 | 8 | 283 | 1,156 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (16,089) | (9,803) | (3,753) | 2,139 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (16,089) | (9,803) | (3,753) | 2,139 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($16,089) | ($9,803) | ($3,753) | $2,139 |
|
2.03% Nasdaq 0.00%
Income Statement
